LED-emitted blue light improves quality of life and reduces fatigue after COVID-19 infection

Daniel Nolberczak; Aleksandra Lesiak; Rafał Czajkowski; Igor Aleksander Bednarski; Joanna Narbutt

doi:10.5114/ada.2024.144522

eISSN: 2299-0046
ISSN: 1642-395X

Advances in Dermatology and Allergology/Postępy Dermatologii i Alergologii

Current issue Archive Manuscripts accepted About the journal Editorial board Reviewers Abstracting and indexing Subscription Contact Instructions for authors Publication charge Ethical standards and procedures

Editorial System

Submit your Manuscript

Editorial Policies

Sarajevo Declaration on Integrity and Visibility of Scholarly Publications

5/2024
vol. 41

Send email

Copy url:

abstract:

Original paper

LED-emitted blue light improves quality of life and reduces fatigue after COVID-19 infection

Daniel Nolberczak

¹

,

Aleksandra Lesiak

¹

,

Rafał Czajkowski

²

,

Igor Aleksander Bednarski

³

,

Joanna Narbutt

¹

Department of Dermatology, Paediatric Dermatology and Dermatological Oncology, Medical University of Lodz, Poland
Department of Dermatology and Venerology, Collegium Medicum in Bydgoszcz, Nicolaus Copernicus University in Torun, Poland
Department of Neurology, Medical University of Lodz, Poland

Adv Dermatol Allergol 2024; XLI (5): 515-520

DOI: https://doi.org/10.5114/ada.2024.144522

Online publish date: 2024/10/28

View full text Get citation

Introduction:
Despite multiple clinical presentations of long COVID, the most common symptom encountered by the patients is fatigue which significantly impacts daily functioning and quality of life. There are, however, multiple unanswered questions regarding the treatment of fatigue among long COVID patients. Several studies highlighted that repetitive exposure to blue light may alleviate the fatigue in different groups of patients but the studies on the efficacy of blue light therapy in treatment of fatigue in long COVID patients are lacking.

Aim:
To evaluate the effects of blue light therapy in treatment of fatigue among COVID-19 survivors.

Material and methods:
The study comprised of 43 adults who underwent COVID-19 infection with a subjective feeling of fatigue 4 weeks after the infection. All participants underwent 10 full-body blue light irradiation for 15 min a day for 5 consecutive days each week. All participants were assessed using the Fatigue Severity Scale (FSS), Short Form 36 Vitality Subscale (SF-36) and Dermatology Life Quality Index (DLQI). Serum samples were taken to measure the levels of tryptophan, kynurenine, kynurenic acid, quinolinic acid and serotonin before and after irradiation.

Results:
Irradiation with blue light resulted in a significant decrease in FSS and DLQI as well as in an increase in SF-36 and serum levels of tryptophan, kynurenine and serotonin.

Conclusions:
Our study shows that blue light therapy could be used as adjunctive treatment of fatigue and provide an opportunity for further scientific inquiries.

keywords:

LED-emitted blue light improves quality of life and reduces fatigue after COVID-19 infection

Daniel Nolberczak 1 , Aleksandra Lesiak 1 , Rafał Czajkowski 2 , Igor Aleksander Bednarski 3 , Joanna Narbutt 1

blue light therapy, post-COVID fatigue, psychological consequences of COVID, FSS, SF-36 scale

Daniel Nolberczak

¹

,

Aleksandra Lesiak

¹

,

Rafał Czajkowski

²

,

Igor Aleksander Bednarski

³

,

Joanna Narbutt

¹